Phase Ib/II Study Of Batiraxcept (Bt, Avb-S6-500, An Axl Pathway Inhibitor) In Combination With Cabozantinib (Cabo) In Patients With Advanced Clear Cell Renal Cell Carcinoma (Ccrcc) Who Failed First-Line (1L) Therapy
Batiraxcept;Cabozantinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase Ib/II Study Of Batiraxcept (Bt, Avb-S6-500, An Axl Pathway Inhibitor) In Combination With Cabozantinib (Cabo) In Patients With Advanced Clear Cell Renal Cell Carcinoma (Ccrcc) Who Failed First-Line (1L) Therapy ### Output: Batiraxcept;Cabozantinib